IL17A and pancreatic neoplasm: Overall, this study provides new insights into the effects of IL17A in modulating the intensity of both antigen‐specific humoral and cellular responses and the anti‐tumour response induced by a DNA anti‐cancer vaccine in pancreatic cancer.